November 2024 Editor's Picks
Nov 01, 2024•19 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist.
Analysis of Gout Remission Definitions in a Randomized Controlled Trial of Colchicine Prophylaxis for People With Gout Initiating Allopurinol - doi.org/10.3899/jrheum.2024-0400
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study - doi.org/10.3899/jrheum.2024-0053
Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries - doi.org/10.3899/jrheum.2024-0252
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study - doi.org/10.3899/jrheum.2024-0298
Systemic Sclerosis Sine Scleroderma: A Time of Reappraisal - doi.org/10.3899/jrheum.2023-1113
For the best experience, listen in Metacast app for iOS or Android